SC
SGYP

Sculptor Capital’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Sculptor Capital’s Portfolio SGYP Stock Details SGYP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-444,200
Closed -$991K – 251
2017
Q4 		$991K Buy
444,200
+346,100
+353% +$860K ﹤0.01% 235
2017
Q3 		$284K Buy
+98,100
New +$335K ﹤0.01% 318

Other funds holding SGYP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HP
Hikari Power Tokyo, Japan $855M AUM 14.24% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return

Sculptor Capital's SGYP Position: Q1 2018 in Review

Sculptor Capital sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q1 2018, closing a stake of 444,200 shares — an estimated $991K sold.

Sculptor Capital first reported a position in SGYP in Q3 2017 and held it in 2 quarters. The position peaked at $991K in Q4 2017. 147 funds tracked by Wall St. Rank hold SGYP as of Q1 2018.

  • Sculptor Capital reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q1 2018 after selling out during the quarter.
  • Sculptor Capital sold 444,200 Synergy Pharmaceuticals, Inc Common Stock shares in Q1 2018, an estimated $991K.
  • Sculptor Capital first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q3 2017 and held it in 2 quarters.
  • Sculptor Capital's Synergy Pharmaceuticals, Inc Common Stock position peaked at $991K in Q4 2017.
  • 147 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q1 2018.

Based on Sculptor Capital's 13F filing for Q1 2018, filed 14 May 2018.